Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Long-term kidney outcomes after COVID-19: a matched cohort study using the OpenSAFELY platform.
MAHALINGASIVAM, V; Zheng, B; Wing, K; PARKER, EP K; BHASKARAN, K; Carrero, JJ; Jayacodi, S; Jumbo, E; Miah, T; Gracey, B; TAZARE, J; Santhakumaran, S; Mathur, R; COSTELLO, RE; HERRETT, E; Wen, Q; Hartney, T; DOUGLAS, IJ; Green, A; Fisher, L; Curtis, HJ; Walker, AJ; MacKenna, B; Hulme, WJ; Mehrkar, A; ... TOMLINSON, L.
2025
The Lancet Regional Health - Europe, (2025).55, 10.1016/j.lanepe.2025.101338.
Optimizing TB policies using the global TB portfolio model: an economic analysis.
Satyanarayana, S; Mandal, S; McQuaid, F; Nair, S; Sahu, S; Menzies, NA; SWEENEY, S; Sanders, R; Baena, IG; WHITE, RG; Adam, T; Smit, M; Pretorius, C;
2025
medRxiv (2025). 10.1101/2025.06.03.25328801.
Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants.
Cobelens, F; Pelzer, PT; Churchyard, GJ; Garcia-Basteiro, A; Hatherill, M; Hill, PC; Martinez, L; WHITE, RG;
2025
Vaccine, (2025).61, 10.1016/j.vaccine.2025.127301.
Effect of the 2022 COVID-19 booster vaccination campaign in people aged 50 years in England: Regression discontinuity analysis in OpenSAFELY-TPP.
Schaffer, AL; Hulme, WJ; Horne, E; PARKER, EP K; Walker, V; Stables, C; Mehrkar, A; Bacon, SC J; Bates, C; Goldacre, B; Walker, AJ; OpenSAFELY Collaborative,; Hernán, MA; Sterne, JA C;
2025
Vaccine, (2025).59, 10.1016/j.vaccine.2025.127257.
Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study.
Wang, C; Lai, X; ABBAS, K; Pouwels, KB; Zhang, H; Jit, M; Fang, H;
2025
The Lancet Public Health, (2025).10 12 10.1016/S2468-2667(25)00039-8.
Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis.
Berrueta, M; Ciapponi, A; Mazzoni, A; Ballivian, J; Bardach, A; Sambade, JM; Brizuela, M; Stegelman, K; Comandé, D; PARKER, EP K; Stergachis, A; Xiong, X; Munoz, FM; Buekens, PM;
2025
Reproductive health, (2025).22 1 10.1186/s12978-025-02004-2.
Safety, immunogenicity, efficacy, and effectiveness of Lassa fever vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis.
Ballivian, J; Berrueta, M; Ciapponi, A; Sambade, JM; Stegelmann, K; Mazzoni, A; Bardach, A; Brizuela, M; Comandé, D; Castellana, N; PARKER, EP K; Stergachis, A; Xiong, X; Munoz, FM; Buekens, PM;
2025
Reproductive health, (2025).22 1 10.1186/s12978-025-02008-y.
Hybrid, vaccine-induced and natural immunity against SARS-CoV-2 in traditional food markets in Bolivia (2020-2022): A cross-sectional analysis of a serological survey.
Leyns, C; MCCLENAGHAN, E; Rodriguez, P; NGUIPDOP-DJOMO, P; Ascarrunz, C; Eid Rodriguez, D; MANGTANI, P; Guitian, J;
2025
Vaccine, (2025).54, 10.1016/j.vaccine.2025.127104.
Qualitative evaluation of two London Faith and Health Networks: lessons learnt from a model of an interface between health systems and minority communities.
Zuriaga-Alvaro, A; KASSTAN-DABUSH, B; Johnson, E; CHANTLER, T; Weil, LG;
2025
BMJ public health, (2025).3 1 10.1136/bmjph-2024-001889.
Population impact of new TB vaccines may depend on efficacy against infectious asymptomatic TB: a modelling study.
TANVIR, H; CLARK, R; SUMNER, T; HORTON, K; Prŷs-Jones, T; Bakker, R; Rade, K; Mave, V; Hatherill, M; Churchyard, G; HOUBEN, RM G J; WHITE, R;
2025
medRxiv (2025). 10.1101/2025.03.24.25323816.